294 Chapter 11 19. Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Noncardiomyocyte Contributions to Heart Disease. Cell Stem Cell. 2020;26: 862–879.e11. 20. Richards DJ, Li Y, Kerr CM, Yao J, Beeson GC, Coyle RC, et al. Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity. Nature Biomedical Engineering. 2020;4: 446–462. 21. Tenreiro MF, Louro AF, Alves PM, Serra M. Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering. npj Regenerative Medicine. 2021;6: 1–17. 22. Hansen A, Eder A, Bönstrup M, Flato M, Mewe M, Schaaf S, et al. Development of a drug screening platform based on engineered heart tissue. Circ Res. 2010;107: 35–44. 23. McDermott-Roe C, Lv W, Maximova T, Wada S, Bukowy J, Marquez M, et al. Investigation of a dilated cardiomyopathy–associated variant in BAG3 using genome-edited iPSC-derived cardiomyocytes. JCI Insight. 2019. doi:10.1172/jci.insight.128799 24. Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure - Full Text View - ClinicalTrials.gov. [cited 29 Apr 2022]. Available: https://clinicaltrials.gov/ct2/show/NCT04396899 25. Ronaldson-Bouchard K, Ma SP, Yeager K, Chen T, Song L, Sirabella D, et al. Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature. 2018;556: 239. 26. Oh JG, Dave J, Kho C, Stillitano F. Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and HighQuality Cell Preparations for Calcium Handling Characterization. JoVE (Journal of Visualized Experiments). 2020; e60135. 27. Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat Protoc. 2013;8: 162. 28. Feyen DAM, McKeithan WL, Bruyneel AAN, Spiering S, Hörmann L, Ulmer B, et al. Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes. Cell Rep. 2020;32: 107925. 29. van Ineveld RL, Ariese HCR, Wehrens EJ, Dekkers JF, Rios AC. Single-Cell Resolution Three-Dimensional Imaging of Intact Organoids. J Vis Exp. 2020 [cited 19 May 2022]. doi:10.3791/60709 30. Ding B, Sun G, Liu S, Peng E, Wan M, Chen L, et al. Three-Dimensional Renal Organoids from Whole Kidney Cells: Generation, Optimization, and Potential Application in Nephrotoxicology In Vitro. Cell Transplant. 2020;29: 963689719897066. 31. Denning C, Borgdorff V, Crutchley J, Firth KSA, George V, Kalra S, et al. Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform. Biochim Biophys Acta. 2016;1863: 1728. 32. Daily NJ, Yin Y, Kemanli P, Ip B, Wakatsuki T. Improving Cardiac Action Potential Measurements: 2D and 3D Cell Culture. J Bioeng Biomed Sci. 2015;5. doi:10.4172/2155-9538.1000168 33. Preininger MK, Singh M, Xu C. Cryopreservation of Human Pluripotent Stem Cell-derived Cardiomyocytes: Strategies, Challenges, and Future Directions. Adv Exp Med Biol. 2016;951: 123. 34. Kim YY, Ku SY, Liu HC, Cho HJ, Oh SK, Moon SY, et al. Cryopreservation of human embryonic stem cells derivedcardiomyocytes induced by BMP2 in serum-free condition. Reprod Sci. 2011;18. doi:10.1177/1933719110385130 35. Daily MI, Whale TF, Partanen R, Harrison AD, Kilbride P, Lamb S, et al. Cryopreservation of primary cultures of mammalian somatic cells in 96-well plates benefits from control of ice nucleation. Cryobiology. 2020;93: 62–69. 36. Zhang JZ, Belbachir N, Zhang T, Liu Y, Shrestha R, Wu JC. Effects of Cryopreservation on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Assessing Drug Safety Response Profiles. Stem Cell Reports. 2021;16: 168–181.
RkJQdWJsaXNoZXIy MTk4NDMw